Lactobacillus plantarum AR495 improves stress-induced irritable bowel syndrome in rats by targeting gut microbiota and Mast cell-PAR2-TRPV1 signaling pathway

K. Angmo. Probiotic characterization of lactic acid bacteria isolated from fermented foods and beverage of Ladakh. 2016, 66: 428-435. I. Bhushan. Bioactive compounds and probiotics–a ray of hope in COVID-19 management. 2021, 10: 131-140. T. Wang. The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment. 2021, 12. B.M. Daliri. New perspectives on probiotics in health and disease. 2015, 4(2): 56-65. Y. Xia. Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition. 2020, 67: 103854. D. Das. Antioxidant activity and γ-aminobutyric acid (GABA) producing ability of probiotic Lactobacillus plantarum DM5 isolated from Marcha of Sikkim. 2015, 61: 263-268. Q.S. Wang. Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrhea. 2021, 12: 2211. E. Zannini. Low FODMAPs and gluten-free foods for irritable bowel syndrome treatment: lights and shadows. 2017, 110: 33-41. M.I. Pinto-Sanchez. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. 2017, 153(2): 448. T. Ringel-Kulka. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. 2014, 40(2): 200-207. B. Fba. In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. 2019, 120: 595-602. C.L. Williams. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. 1988, 94(3): 611-621. Y.J. Li. Mechanisms of probiotic VSL#3 in a rat model of visceral hypersensitivity involves the mast cell-PAR2-TRPV1 pathway. 2018, 64(5): 1182-1192. J.H. La. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. 2003, 9(12): 2791-2795. H. Shimpo. Regulation of prostaglandin E2 synthesis in cells derived from chondrocytes of patients with osteoarthritis. 2009, 14(5): 611-617. S. Murthy.. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. 1993, 38(9): 1722-1734. S. Zhang. A sensitive GC/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples. 2019, 196: 249-254. Q. Wang. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. 2007, 73: 5261-5267. S.F. Chen. fastp: an ultra-fast all-in-one FASTQ preprocessor. 2018, 34: i884-i890. X. Su. Enhanced degradation of biphenyl from PCB-contaminated sediments: the impact of extracellular organic matter from Micrococcus luteus. 2014, 99(4). J. Ritchie. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. 1973, 14(2). W. Whitehead. Tolerance for rectosigmoid distention in irritable bowel syndrome. 1990, 98. G. Barbara. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 2004, 126(3): 693-702. G. Barbara. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. 2007, 132(1): 26-37. M. Guilarte. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. 2007, 56(2): 203-9. G. Barbara. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. 2007, 132(1): 26-37. M.M. Wouter. The role of mast cells in functional GI disorders. 2016, 65(1): 155. H. Liu. Paterso, proteinase-activated receptor-2 activation evokes oesophageal longitudinal smooth muscle contraction via a capsaicin-sensitive and neurokinin-2 receptor-dependent pathway. 2010, 22(2). R.E. Ley. Microbial ecology: human gut microbes associated with obesity. 2006, 444(7122): 1022-1023. E.B. Hollister. Relationships of microbiome markers with extraintestinal, psychological distress and gastrointestinal symptoms, and quality of life in women with irritable bowel syndrome. 2020 R. Mars. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. 2020, 182: 1460-1473. E.B. Troy. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. 2010, 15. H. Luo. Roles of tight junction protein claudins phosphorylation in gastrointestinal barrier function. 2011, 16(7): 438-441. O.R. Colegio. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. 2003, 284(6): 1346-1354. J.D. Schulzke. Tight junctions: molecular structure meets function. 2009, 1165: 1-6. Z. Fehervari. Maintaining barrier. 2015, 16(7): 688. M.A. Azcárate-Peril. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?. 2011 E.M. Quigley. Irritable bowel syndrome; update on pathophysiology and management. 2012, 23(4): 313-322. K. Kasakura. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells. 2009, 50(4): 359-369. P. Forsythe. Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation. 2012, 7. A. Ait-Belgnaoui. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. 2006, 55(8): 1090. C. Rolland-Fourcade. Epithelial expression and function of trypsin-3 in irritable bowel syndrome. 2015, 42(1): 71. Y. Bhattarai. Irritable bowel syndrome: a gut microbiota-related disorder. 2016, 312(1). Y. Liu. Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: a randomized, double-blind, placebo-controlled. 2021, 7(3): 10. F. Durchschein. Diet therapy for inflammatory bowel diseases: the established and the new. 2016 L.H. Augenlicht. Modulation of gene expression as a biomarker in colon. 2010, 50. J.M. Mariadason. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. 1997, 272: 705-712. C.S. Reigstad. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. 2015, 29(4). Z. Xia. Oral administration of propionic acid during lactation enhances the colonic barrier function. 2017, 16(1): 62.